These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 23137282)

  • 1. Transforming pluripotency: an exon-level study of malignancy-specific transcripts in human embryonal carcinoma and embryonic stem cells.
    Alagaratnam S; Harrison N; Bakken AC; Hoff AM; Jones M; Sveen A; Moore HD; Andrews PW; Lothe RA; Skotheim RI
    Stem Cells Dev; 2013 Apr; 22(7):1136-46. PubMed ID: 23137282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A DNMT3B alternatively spliced exon and encoded peptide are novel biomarkers of human pluripotent stem cells.
    Gopalakrishna-Pillai S; Iverson LE
    PLoS One; 2011; 6(6):e20663. PubMed ID: 21698279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiation of human embryonal carcinomas in vitro and in vivo reveals expression profiles relevant to normal development.
    Skotheim RI; Lind GE; Monni O; Nesland JM; Abeler VM; Fosså SD; Duale N; Brunborg G; Kallioniemi O; Andrews PW; Lothe RA
    Cancer Res; 2005 Jul; 65(13):5588-98. PubMed ID: 15994931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The transcriptome profile of human embryonic stem cells as defined by SAGE.
    Richards M; Tan SP; Tan JH; Chan WK; Bongso A
    Stem Cells; 2004; 22(1):51-64. PubMed ID: 14688391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanog regulates molecules involved in stemness and cell cycle-signaling pathway for maintenance of pluripotency of P19 embryonal carcinoma stem cells.
    Choi SC; Choi JH; Park CY; Ahn CM; Hong SJ; Lim DS
    J Cell Physiol; 2012 Nov; 227(11):3678-92. PubMed ID: 22378194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of Wnt and Notch pathway genes in a pluripotent human embryonal carcinoma cell line and embryonic stem cell.
    Walsh J; Andrews PW
    APMIS; 2003 Jan; 111(1):197-210; discussion 210-1. PubMed ID: 12760378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wnt pathway reprogramming during human embryonal carcinoma differentiation and potential for therapeutic targeting.
    Snow GE; Kasper AC; Busch AM; Schwarz E; Ewings KE; Bee T; Spinella MJ; Dmitrovsky E; Freemantle SJ
    BMC Cancer; 2009 Oct; 9():383. PubMed ID: 19874621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene expression patterns in human embryonic stem cells and human pluripotent germ cell tumors.
    Sperger JM; Chen X; Draper JS; Antosiewicz JE; Chon CH; Jones SB; Brooks JD; Andrews PW; Brown PO; Thomson JA
    Proc Natl Acad Sci U S A; 2003 Nov; 100(23):13350-5. PubMed ID: 14595015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reprogramming in inter-species embryonal carcinoma-somatic cell hybrids induces expression of pluripotency and differentiation markers.
    Flasza M; Shering AF; Smith K; Andrews PW; Talley P; Johnson PA
    Cloning Stem Cells; 2003; 5(4):339-54. PubMed ID: 14733752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extrinsic factors derived from mouse embryonal carcinoma cell lines maintain pluripotency of mouse embryonic stem cells through a novel signal pathway.
    Kawazoe S; Ikeda N; Miki K; Shibuya M; Morikawa K; Nakano S; Oshimura M; Hisatome I; Shirayoshi Y
    Dev Growth Differ; 2009 Feb; 51(2):81-93. PubMed ID: 19207180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. hnRNPLL controls pluripotency exit of embryonic stem cells by modulating alternative splicing of Tbx3 and Bptf.
    Wang X; Ping C; Tan P; Sun C; Liu G; Liu T; Yang S; Si Y; Zhao L; Hu Y; Jia Y; Wang X; Zhang M; Wang F; Wang D; Yu J; Ma Y; Huang Y
    EMBO J; 2021 Feb; 40(4):e104729. PubMed ID: 33349972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear magnetic resonance detects phosphoinositide 3-kinase/Akt-independent traits common to pluripotent murine embryonic stem cells and their malignant counterparts.
    Romanska HM; Tiziani S; Howe RC; Günther UL; Gulzar Z; Lalani el-N
    Neoplasia; 2009 Dec; 11(12):1301-8. PubMed ID: 20019838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detailed characterization of the mouse embryonic stem cell transcriptome reveals novel genes and intergenic splicing associated with pluripotency.
    Kunarso G; Wong KY; Stanton LW; Lipovich L
    BMC Genomics; 2008 Apr; 9():155. PubMed ID: 18400104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ectopic activation of WNT signaling in human embryonal carcinoma cells and its effects in short- and long-term in vitro culture.
    Atlasi Y; van Dorsten RT; Sacchetti A; Joosten R; Oosterhuis JW; Looijenga LHJ; Fodde R
    Sci Rep; 2019 Aug; 9(1):11928. PubMed ID: 31417131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome-wide gain-of-function screen identifies novel regulators of pluripotency.
    Abujarour R; Efe J; Ding S
    Stem Cells; 2010 Sep; 28(9):1487-97. PubMed ID: 20629179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retinoic acid directs neuronal differentiation of human pluripotent stem cell lines in a non-cell-autonomous manner.
    Tonge PD; Andrews PW
    Differentiation; 2010 Jul; 80(1):20-30. PubMed ID: 20427117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective repression of retinoic acid target genes by RIP140 during induced tumor cell differentiation of pluripotent human embryonal carcinoma cells.
    Heim KC; White KA; Deng D; Tomlinson CR; Moore JH; Freemantle SJ; Spinella MJ
    Mol Cancer; 2007 Sep; 6():57. PubMed ID: 17880687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A data integration approach to mapping OCT4 gene regulatory networks operative in embryonic stem cells and embryonal carcinoma cells.
    Jung M; Peterson H; Chavez L; Kahlem P; Lehrach H; Vilo J; Adjaye J
    PLoS One; 2010 May; 5(5):e10709. PubMed ID: 20505756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression profiling in transgenic FVB/N embryonic stem cells overexpressing STAT3.
    Cinelli P; Casanova EA; Uhlig S; Lochmatter P; Matsuda T; Yokota T; Rülicke T; Ledermann B; Bürki K
    BMC Dev Biol; 2008 May; 8():57. PubMed ID: 18500982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual roles of Oct4 in the maintenance of mouse P19 embryonal carcinoma cells: as negative regulator of Wnt/β-catenin signaling and competence provider for Brachyury induction.
    Marikawa Y; Tamashiro DA; Fujita TC; Alarcon VB
    Stem Cells Dev; 2011 Apr; 20(4):621-33. PubMed ID: 21083502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.